Read the current Defeat Diabetes® E-Lerts™ Newsletter

This website is certified by Health On the Net Foundation. Click to verify.
This site complies with the HONcode standard for trustworthy health information:
verify here.

 
 
 
     
Rewarding for
you and us

Defeat Diabetes Foundation
    
      
       
Defeat Diabetes
Foundation
150 153rd Ave,
Suite 300

Madeira Beach, FL 33708
  

Scientists Working On A New Insulin Pill

Posted: Saturday, July 14, 2007

Insulin injections may soon be a thing of the past. 

A British company has developed a form of the protein that can be taken orally. Scientists at Diabetology, a small research and development company that has spent may years trying to develop oral insulin, believe that it will better control of symptoms. The company has successfully enclosed the insulin in a capsule that prevents it from being digested by stomach acids, and carries it intact into the small intestine. Once the capsule has reached the small intestine, it is dissolved and releases a mixture of insulin and other materials that enhance the absorption of the insulin through the intestinal wall. Thereafter, the insulin is transported to the liver, where it creates a store that can be drawn on by the body.

The researchers say that the mechanism by which the capsule carries insulin into the body approximates the behavior of the pancreas, the source of insulin in healthy people that releases it as it is needed. Diabetology has already carried out a small trial of 16 patients with type 2 diabetes, the commoner type that usually develops in middle age, led by Cardiff University Professor David Owens. Dr Steve Luzio, another researcher at the university, presented the results of the trial at the American Diabetes Association meeting in Chicago. He announced that the oral dose taken twice daily before breakfast and before dinner, controlled glucose levels successfully in the patients treated. Glen Travers, the Executive Chairman of Diabetology, hopes that the product will enable better control of the disease to be achieved, without the increased risk of heart attack that has been linked to the widely used diabetes drug rosiglitazone.

Source: Diabetes In Control: ADA Scientific Sessions June 2007

 
 
 
 
 
Join us on Facebook
 
 
 
 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.  
 
 

Send your unopened, unexpired test strips to:


Defeat Diabetes Foundation
150 153rd Ave, Suite 300
Madeira Beach, FL 33708

 

DDF advertisement
 

 Friendly Banner
 


Friendly Banner
 
 
 
Analyze nutrition content by portion
DDF advertisement